99% of Heart Attack, Stroke, Heart Failure Cases Linked to Preventable Risk Factors

Translate to Spanish or other 102 languages!

Scientists also found that of the four major cardiovascular disease risk factors studied, high blood pressure was the most common issue. Image for illustration purposes
Scientists also found that of the four major cardiovascular disease risk factors studied, high blood pressure was the most common issue. Image for illustration purposes
- Advertisement -

Medical News Today

A new study of more than 9,000 adults reports that more than 99% of people who experienced a heart attack, heart failure, or stroke had at least one of four major cardiovascular risk factors — high blood pressure, cholesterol, or fasting glucose, as well as tobacco use — above ideal healthy levels beforehand. 

Scientists also found that of the four major cardiovascular disease risk factors studied, high blood pressure was the most common issue.

- Advertisement -

Follow the link below to read the full story at Medical News Today:

https://www.medicalnewstoday.com/articles/heart-attack-stroke-heart-failure-linked-to-preventable-risk-factors?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-09-30&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Recognizes November as “National Hospice and Palliative Care” Month

DHR Health is pleased to recognize November as “National Hospice and Palliative Care Month.”  As we highlight National Hospice and Palliative Care Month, let us remember that healthcare is not solely about treating diseases but also about care for people at end of life.

STHS Heart Earns Healthgrades Five-Star Rating for Pacemaker Procedures

Healthgrades, the leading online resource for information about physicians and hospitals, has named STHS Heart a Five-Star Recipient for Pacemaker Procedures in 2027 for the second consecutive year, recognizing the facility's superior clinical outcomes and commitment to patient care.

AMA Advises Patients to Check with Doctors on Web Advice

The internet offers no shortage of health advice. But with misleading medical claims spread across social media, search engines, and AI platforms, finding trustworthy answers can be a challenge. 

FDA Authorizes Focused Ultrasound Treatment for Varicose Veins

Theraclion has announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for its Sonovein device to treat superficial venous reflux in great saphenous veins (GSV), the main cause of varicose veins. This is the first noninvasive focused ultrasound platform to treat varicose veins, which affect approximately one third of adults.
- Advertisement -